Inconsistencies in Reporting Blinding in Clinical Trials
Author Information
Author(s): Zhang Fengying MSc, Zhu Yi MPH, Zhao Shengmin MSc, Zhang Qian MPH, Tao Huan MSc, Wu Yunhong PhD, Jia Pengli PhD
Primary Institution: Tibet Autonomous Region Clinical Research Center for High-Altitude Stress, Endocrinology and Metabolism Disease, Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region
Hypothesis
Does inconsistency exist in blinding status reports between publications and corresponding trial registries?
Conclusion
The study found significant inconsistencies in the reporting of blinding between trial publications and their corresponding registries.
Supporting Evidence
- 80.6% of trials showed inconsistencies in blinding information.
- Single-center trials had higher odds of reporting inconsistencies.
- Cancer-focused studies had notably higher odds of inconsistencies.
Takeaway
This study looked at clinical trials and found that many of them didn't report blinding information consistently, which can lead to confusion about how the trials were conducted.
Methodology
The study conducted a systematic review comparing blinding information in trial registries and published articles for randomized clinical trials.
Potential Biases
Inconsistencies in reporting may lead to misinterpretation of trial results and affect evidence-based practices.
Limitations
The analysis was limited to systematic reviews from a specific 5-year period and may not represent all relevant evidence.
Participant Demographics
The trials included a median sample size of 338 participants, with a focus on various diseases, primarily cancer.
Statistical Information
P-Value
P < .001
Confidence Interval
95% CI, 1.24-7.74
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website